- Home
- DPRO vs ERNA Comparison
DPRO vs ERNA Comparison
Compare DPRO & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- ERNA
- Stock Information
- Founded
- DPRO 1998
- ERNA 2018
- Country
- DPRO Canada
- ERNA United States
- Employees
- DPRO N/A
- ERNA N/A
- Industry
- DPRO Aerospace
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- ERNA Health Care
- Exchange
- DPRO Nasdaq
- ERNA Nasdaq
- Market Cap
- DPRO 13.0M
- ERNA 14.5M
- IPO Year
- DPRO N/A
- ERNA N/A
- Fundamental
- Price
- DPRO $2.81
- ERNA $0.22
- Analyst Decision
- DPRO Strong Buy
- ERNA
- Analyst Count
- DPRO 2
- ERNA 0
- Target Price
- DPRO $7.00
- ERNA N/A
- AVG Volume (30 Days)
- DPRO 78.0K
- ERNA 207.7K
- Earning Date
- DPRO 05-13-2025
- ERNA 05-13-2025
- Dividend Yield
- DPRO N/A
- ERNA N/A
- EPS Growth
- DPRO N/A
- ERNA N/A
- EPS
- DPRO N/A
- ERNA N/A
- Revenue
- DPRO $4,559,961.00
- ERNA $582,000.00
- Revenue This Year
- DPRO $94.01
- ERNA N/A
- Revenue Next Year
- DPRO $95.14
- ERNA N/A
- P/E Ratio
- DPRO N/A
- ERNA N/A
- Revenue Growth
- DPRO 0.10
- ERNA 755.88
- 52 Week Low
- DPRO $1.55
- ERNA $0.15
- 52 Week High
- DPRO $9.13
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- DPRO 56.44
- ERNA 51.52
- Support Level
- DPRO $2.52
- ERNA $0.17
- Resistance Level
- DPRO $2.75
- ERNA $0.21
- Average True Range (ATR)
- DPRO 0.26
- ERNA 0.02
- MACD
- DPRO 0.06
- ERNA 0.01
- Stochastic Oscillator
- DPRO 86.91
- ERNA 93.33
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.